Literature DB >> 6393415

Airways obstruction associated with graft versus host disease after bone marrow transplantation.

S E Wyatt, P Nunn, J M Hows, J Yin, M C Hayes, D Catovsky, E C Gordon-Smith, J M Hughes, J M Goldman, D Galton.   

Abstract

Eight patients, five with chronic granulocytic leukaemia and three with severe aplastic anaemia, developed moderately severe airflow obstruction after allogeneic bone marrow transplantation. All eight had clinically and radiologically normal lungs before undergoing transplantation. Treatment in the patients with chronic granulocytic leukaemia before transplantation included high dose total body irradiation. All eight patients developed acute and chronic graft versus host disease after transplantation. The pulmonary syndrome consisted of cough, dyspnoea, and wheezing beginning six to 20 weeks after transplantation, with ratios of forced expiratory volume in one second (FEV1) to vital capacity (VC) falling to 60% or less of predicted values. The three patients with severe aplastic anaemia had relatively mild graft versus host disease and acute chest infection may have initiated or contributed to their airways obstruction, which subsequently resolved. The five patients with chronic granulocytic leukaemia had more severe graft versus host disease and more progressive respiratory problems; two died and three continued to have persistent airflow obstruction 11, 15, and 20 months after transplantation. None of those with chronic granulocytic leukaemia improved. Transfer factor (TLCO) was reduced in all patients after bone marrow transfer and did not improve; in the patients with chronic granulocytic leukaemia the reduction in TLCO preceded the fall in FEV1/VC ratio. Open lung biopsy in one of the patients with chronic granulocytic leukaemia showed obliterative bronchiolitis with lymphocytic infiltration consistent with graft versus host disease. Bronchodilators were of no benefit in the management of these patients, but prompt treatment of infection and early use of corticosteroids may have contributed to the improvement seen in the patients with severe aplastic anaemia.

Entities:  

Mesh:

Year:  1984        PMID: 6393415      PMCID: PMC459948          DOI: 10.1136/thx.39.12.887

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  17 in total

Review 1.  Bone-marrow transplantation (first of two parts).

Authors:  E Thomas; R Storb; R A Clift; A Fefer; F L Johnson; P E Neiman; K G Lerner; H Glucksberg; C D Buckner
Journal:  N Engl J Med       Date:  1975-04-17       Impact factor: 91.245

2.  A prospective analysis interstitial pneumonia and opportunistic viral infection among recipients of allogeneic bone marrow grafts.

Authors:  P E Neiman; W Reeves; G Ray; N Flournoy; K G Lerner; G E Sale; E D Thomas
Journal:  J Infect Dis       Date:  1977-12       Impact factor: 5.226

3.  Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality.

Authors:  B M Camitta; E D Thomas; D G Nathan; G Santos; E C Gordon-Smith; R P Gale; J M Rappeport; R Storb
Journal:  Blood       Date:  1976-07       Impact factor: 22.113

4.  Iron-deficiency anaemia: its effect on transfer factor for the lung (diffusiong capacity) and ventilation and cardiac frequency during sub-maximal exercise.

Authors:  J E Cotes; J M Dabbs; P C Elwood; A M Hall; A McDonald; M J Saunders
Journal:  Clin Sci       Date:  1972-03       Impact factor: 6.124

5.  Factors associated with interstitial pneumonitis after bone-marrow transplantation for acute leukaemia.

Authors:  M M Bortin; H E Kay; R P Gale; A A Rimm
Journal:  Lancet       Date:  1982-02-20       Impact factor: 79.321

6.  Silo-filler's disease: nitrogen dioxide-induced lung injury. Long-term follow-up and review of the literature.

Authors:  J Ramirez; A R Dowell
Journal:  Ann Intern Med       Date:  1971-04       Impact factor: 25.391

7.  Total body irradiation (TBI) before bone marrow transplantation in leukaemia: a co-operative study from the European Group for Bone Marrow Transplantation.

Authors:  A Barrett
Journal:  Br J Radiol       Date:  1982-08       Impact factor: 3.039

8.  Marrow transplantation for patients in the chronic phase of chronic granulocytic leukaemia.

Authors:  J M Goldman; A S Baughan; D M McCarthy; A M Worsley; J M Hows; E C Gordon-Smith; D Catovsky; J R Batchelor; A W Goolden; D A Galton
Journal:  Lancet       Date:  1982-09-18       Impact factor: 79.321

9.  Cryptogenic obliterative bronchiolitis in adults.

Authors:  C W Turton; G Williams; M Green
Journal:  Thorax       Date:  1981-11       Impact factor: 9.139

10.  Chronic obstructive airway disease in patients with Sjögren's syndrome.

Authors:  H H Newball; S A Brahim
Journal:  Am Rev Respir Dis       Date:  1977-02
View more
  13 in total

1.  Radiation-induced changes in lung tissue and development of fibrosis determined by quantitative morphometric methods.

Authors:  R Kraus; F Steinberg; B Rehn; J Bruch; C Streffer
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

2.  Severe airflow obstruction in a patient with ulcerative colitis and toxic epidermal necrolysis: A case report.

Authors:  Shijima Taguchi; Junichi Furuta; Gen Ohara; Katsunori Kagohashi; Hiroaki Satoh
Journal:  Exp Ther Med       Date:  2015-02-24       Impact factor: 2.447

Review 3.  Bone marrow transplantation and the lung.

Authors:  P J Hamilton; A D Pearson
Journal:  Thorax       Date:  1986-07       Impact factor: 9.139

4.  Pulmonary function after bone marrow transplantation for chronic myeloid leukaemia.

Authors:  T G Sutedja; J F Apperley; J M Hughes; V R Aber; H G Kennedy; P Nunn; L Jones; L Hopper; J M Goldman
Journal:  Thorax       Date:  1988-03       Impact factor: 9.139

5.  Soluble tumor necrosis factor receptor: enbrel (etanercept) for subacute pulmonary dysfunction following allogeneic stem cell transplantation.

Authors:  Gregory A Yanik; Shin Mineishi; John E Levine; Carrie L Kitko; Eric S White; Mark T Vander Lugt; Andrew C Harris; Thomas Braun; Kenneth R Cooke
Journal:  Biol Blood Marrow Transplant       Date:  2011-12-10       Impact factor: 5.742

6.  Lung function changes after allogenic bone marrow transplantation.

Authors:  H Link; U Reinhard; M Blaurock; P Ostendorf
Journal:  Thorax       Date:  1986-07       Impact factor: 9.139

7.  Bronchiolitis obliterans after allogenic bone marrow transplantation: HRCT findings.

Authors:  Jung Im Jung; Won Sang Jung; Seong Tai Hahn; Chang Ki Min; Chun Choo Kim; Seog Hee Park
Journal:  Korean J Radiol       Date:  2004 Apr-Jun       Impact factor: 3.500

8.  High-resolution CT findings of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.

Authors:  Martin L D Gunn; J David Godwin; Jeffrey P Kanne; Mary E Flowers; Jason W Chien
Journal:  J Thorac Imaging       Date:  2008-11       Impact factor: 3.000

9.  Can lung function measurements be used to predict which patients will be at risk of developing interstitial pneumonitis after bone marrow transplantation?

Authors:  H J Milburn; H G Prentice; R M du Bois
Journal:  Thorax       Date:  1992-06       Impact factor: 9.139

10.  Dendritic cells with antigen-presenting capability reside in airway epithelium, lung parenchyma, and visceral pleura.

Authors:  K Sertl; T Takemura; E Tschachler; V J Ferrans; M A Kaliner; E M Shevach
Journal:  J Exp Med       Date:  1986-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.